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We recently purified two closely related 33 kDa proteins from rat hepatic cytosol, designated bile acid binder 
I and II, which selectively bind bile acids with comparable affinity as glutathione S-transferase B. This work 
has now been extended to human liver in which we have identified a similar cytosolic binding activity in 
the 3&40 kDa fraction from gel filtration. Subsequent chromatofocusing and hydroxyapatite chromatog- 
raphy resulted in the isolation of a homogenous monomeric protein of 36 kDa. The binding affinity of this 
protein for lithocholate using the displacement of I-anilino-8-naphthalenesulfonate (ANS) was 0.1 PM, 
whereas human hepatic glutathione S-transferases purified from glutathione affinity chromatography dem- 
onstrated no competitive displacement of ANS. 
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1. INTRODUCTION 
The liver efficiently extracts 70-90% of the bile 
acid pool present during a single pass through the 
liver [l]. Although recent progress has been made 
in elucidating the mechanism of hepatic bile acid 
uptake [2] and canalicular excretion [3], little is 
known about the process of intracellular transloca- 
tion of bile acids. As a first step in understanding 
intracellular bile acid transport, we sought to iden- 
tify cytoplasmic proteins which specifically bind 
bile acids. Previously, it has been widely held that 
the glutathione S-transferases were the predomin- 
ate cytoplasmic bile acid binding proteins [4-61. In 
the rat, we recently isolated a newly recognized 
pair of similar 33 kDa bile acid binding proteins 
(bile acid binders I and II), initially recognized as 
lithocholate binding activity in the 30-40 kDa 
fractions from gel filtration [7,8]. These proteins 
bind most lipophilic bile acids with comparable or 
greater affinity than glutathione S-transferase B. 
Since little is known about human hepatic bile acid 
binding proteins, it was of interest to determine if 
a similar binding activity exists in the 30-40 kDa 
fractions from gel filtration of human hepatic 
cytosol and to purify the protein responsible for 
this activity. 
2. MATERIALS AND METHODS 
2.1. Preparation of cytosol 
Normal human liver was obtained during 
surgical lobectomy for an isolated metastasis from 
colon carcinoma. Tissue was homogenized (33%, 
w/v) in 0.01 M sodium phosphate, pH 7.4 (Buffer 
A) with 0.25 M sucrose. The supernatant (cytosol) 
was harvested after centrifugation at 100000 x g 
for 60 min. 
2.2. Lithocholate binding activity 
Lithocholate binding was determined by 
equilibrium dialysis of individual column fractions 
against 2 1 buffer A with 25 nmol [14C]lithocholate 
(3 yCi) (59 Ci/mmol; Amersham) at 4°C for 48 h 
using Spectrapor Membrane (12-14 kDa exclu- 
sion) (Spectrum Medical Industries, Los Angeles, 
CA). The ratio of bound over free lithocholate for 
individual fractions was calculated by the dif- 
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ference of total dpm minus free dpm divided by 
free dpm [7]. 
2.3. Gel filtration of hepatic cytosol 
Human hepatic cytosol (8 ml) was chromato- 
graphed on a 2.5 x 120 cm Sephadex G-75 super- 
fine (Pharmacia) column eluted with buffer A at 
4°C and fractions were assayed for AZEO, glu- 
tathione (GSH) S-transferase activity by moni- 
toring the conjugation of GSH with I-chloro-2,4- 
dinitrobenzene (CDNB) [9] and lithocholate bind- 
ing activity. 
2.4. Purification of lithocholate binding protein 
Human hepatic cytosol (150 ml) was frac- 
tionated on a 5 x 100 cm Sephadex G-75 sf column 
eluted with buffer A. The 30-40 kDa fractions 
containing lithocholate binding activity were 
pooled, concentrated by ultrafiltration and applied 
to a 1 x 50 cm column of Polybuffer Exchanger 94 
(Pharmacia) equilibrated with 0.025 M imidazole, 
pH 7.4, and eluted with a 1: 8 dilution of polybuf- 
fer 74 (adjusted to pH 4 with HCl) at a flow rate 
of 24 ml/h. Individual fractions (3.5 ml) were 
assayed for .&O, GSH S-transferase activity, 
lithocholate binding and pH. Fractions containing 
lithocholate binding activity from chromatofocus- 
ing were pooled, adjusted to pH 6.7 with dilute 
phosphoric acid and applied to a 0.9 x 27 cm 
hydroxyapatite column (HA-Ultrogel, LKB) 
equilibrated with 0.01 M potassium phosphate, 
pH 6.7 (buffer B). Following elution with 40 ml 
buffer B, the column was eluted with a linear gra- 
dient of 0.025 M potassium phosphate and 0.25 M 
potassium phosphate pH 6.7 (130 ml each). Frac- 
tions were assayed for AXO, lithocholate binding 
activity and conductivity. 
2.5. Purification of human GSH S-transferases 
Fractions from preparative gel filtration con- 
taining GSH S-transferase activity were pooled 
and purified by GSH affinity chromatography us- 
ing S-octylglutathione coupled to epoxy activated 
Sepharose 6B (Pharmacia) [lo]. The product was a 
single band (25 kDa) on SDS-polyacrylamide gel 
electrophoresis (PAGE) and represents a mixture 
of human transferases. 
2.6. SDS-PAGE 
Discontinuous SDS-PAGE was performed ac- 
32 
cording to [l 11. 10 ,JJ of Sigma VII-L molecular 
mass standards were used for calibration of the 
gel, which was stained with Coomassie brilliant 
blue. 
2.7. Amino acid composition 
Purified protein (8Opg) was hydrolyzed with 
2 ml of 12 N HCl in sealed flamed flasks at 110°C 
for 24 h and analyzed on a Beckman 6300 HPLC 
amino acid analyzer using Beckman buffers A, B, 
and D. 
2.0. Binding affinity 
Binding affinity of both the purified human bile 
acid binder and the glutathione S-transferase was 
determined by the competitive displacement of the 
fluorescent probe, I -aniline-8-naphthalenesul- 
fonate (ANS). The fluorescence of bound ANS 
was determined at excitation 400 nm and emission 
480 nm. To determine the affinity of both proteins 
for ANS, each protein was studied at 0.5 PM along 
with increasing concentrations from 0 to 40 pM 
ANS. For inhibition studies, ANS concentrations 
were varied in the absence or presence of lithochol- 
ate (1 PM) for bile acid binder and (2 PM) for the 
GSH S-transferases. Data were analyzed by the 
method of [7]. 
3. RESULTS AND DISCUSSION 
The elution profile of lithocholate binding ac- 
tivity in gel filtration of human hepatic cytosol is 
shown in fig.1. Lithocholate binding activity 
eluted as two peaks: a minor peak corresponding 
to the GSH S-transferase (45-50 kDa) and a major 
peak corresponding to 30-40 kDa. The elution of 
this major peak of lithocholate binding activity 
with human cytosol corresponds almost exactly to 
the elution of the recently identified lithocholate 
binding activity in rat cytosol. In contrast to the 
results with human cytosol, the lithocholate bind- 
ing activity (as determined by equilibrium dialysis) 
in the rat corresponding to the GSH S-transferases 
containing fractions greatly exceeded that of the 
30-40 kDa fractions (not shown). Since we have 
previously shown that the rat GSH S-transferases 
and the newly identified bile acid binders bind 
lithocholate with about the same affinity, the 
greater binding activity of the rat transferase frac- 
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Fig.1. Gel chromatography (Sephadex G-75 sf) of 
human hepatic cytosol (8 ml). Fractions were assayed 
for A280 (t?), GSH S-transferase activity (k--A), 
and lithocholate binding (c--o). 
tion in gel filtration is probably due to its greater 
cytoplasmic content. The contrary result with 
human cytosol (fig. 1) suggests either a higher bind- 
ing affinity and/or greater binding capacity for 
lithocholate by the newly identified human bile 
acid binder. 
In order to isolate the lithocholate binding pro- 
tein, a large pool of human hepatic cytosol 
(150 ml) was fractionated on a preparative 
Sephadex G-75 sf column which gave the same 
separation as shown in fig. 1 (not shown). The frac- 
tions with peak lithocholate binding activity were 
pooled, concentrated and separated by chromato- 
focusing (fig.2). The majority of the lithocholate 
binding activity eluted in a single peak at pH 7.32. 
Nearly identical results were obtained with another 
human liver (not shown). Other minor lithocholate 
binding peaks eluted at both higher and lower pH 
and were not further characterized. The bulk of 
GSH S-transferase activity eluted prior to the pH 
gradient and represents the cationic enzymes. The 
major lithocholate binding peak did not exhibit 
GSH S-transferase activity. Fractions 44-52 from 
chromatofocusing were pooled, adjusted to pH 6.7 
and further purified by hydroxyapatite chroma- 
tography. The lithocholate binding activity co- 
eluted with the major protein peak (fig.3). 
Fig.4 shows the SDS-PAGE of the sequential 
steps in the purification of the lithocholate binder. 
The lithocholate binding activity peak from 
hydroxyapatite was a single band indicating that it 
is a monomeric protein of 36 kDa. The amino acid 
composition of the purified human lithocholate 
binder is shown in table 1. Aside from the higher 
valine and isoleucine content, the human protein 
shows remarkable similarity to the rat binder [7]. 
Lithocholate binding affinity of both the 
purified human GSH S-transferases and the bile 
acid binder were determined by the ANS displace- 
Fig.2. Chromatofocusing of the lithocholate binding activity from 30 to 40 kDa from preparative gel filtration. 
Fractions were assayed for A280 (o---o), GSH Stransferase activity (A---A), lithocholate binding (G--O), 
and pH (x). 
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Fig.3. Hydroxyapatite chromatography of major 
lithocholate binding activity from chromatofocusing. 
Fractions were assayed for &se (M), lithocholate 
binding (@--o) and conductivity (x). 
ment method. The Kd for ANS binding was 13 ,uM 
for the bile acid binder and 16 PM for GSH 
S-transferase. Lithocholate competitively inhibited 
Table 1 
Amino acid composition of human bile acid binder 
Amino acid Human binder 
Aspartic acid 35.3 
Threonine” 10.4 
Serinea 19.6 
Glutamic acid 35.4 
Prolineb 19.0 
Glycine 20.0 
Alanine 26.0 
ValineC 26.4 
Methionineb 3.4 
Isoleucine’ 15.4 
LeucineC 35.2 
Tyrosineb 11.6 
Phenylalanine 12.9 
Histidine 8.9 
Lysine 25.7 
Arginine 14.4 
a Extrapolated to zero time from 24- and 72-h 
incubation 
b 24-h incubation result 
’ 72-h incubation result 
Results are expressed as amino acid analysis of mol 
amino acid/m01 protein (mean of 4 determinations; two 
incubated for 24 h and two for 72 h) 
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Fig.4. Lanes A and F, molecular mass standards; lane B, 
6-8 ,ug protein from the pooled fractions with litho- 
cholate binding activity from hydroxyapatite chroma- 
tography; lane C, 15 pg proteins from the pooled major 
lithocholate binding peak from chromatofocusing; lane 
D, 20 pg protein from pooled 30-40 kDa fractions from 
gel filtration; lane E, 3Opg hepatic cytosolic protein. 
the ANS binding bile acid binder (not shown). The 
K, for lithocholate was 0.1 PM with the bile acid 
binder. No inhibition of ANS binding to GSH 
S-transferase was detected. These data, coupled 
with the greater lithocholate binding activity of the 
30-40 kDa fractions from gel filtration of hepatic 
cytosol (fig.l), suggest that the human bile acid 
binder which we have identified binds lithocholate 
with markedly greater affinity than human GSH 
S-transferase. Further work will be required to 
assess the relative binding of various bile acids 
using several techniques to determine the binding 
affinities and specificities of these proteins. 
In summary, we have identified and purified a 
unique lithocholate binder in human hepatic 
cytosol which is similar to the forms we have 
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previously found in the rat. The precise role of this 
binder in intracellular bile acid transport or storage 
remains to be determined. 
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